Assessment of intra- and interobserver reproducibility of rest and cold pressor test-stimulated myocardial blood flow with 13N-ammonia and PET
暂无分享,去创建一个
John O. Prior | James Sayre | Thomas H. Schindler | Magnus Dahlbom | H. Schelbert | J. Sayre | M. Dahlbom | T. Schindler | Heinrich R. Schelbert | Xiao-Li Zhang | Jerson Cadenas | J. Cadenas | Xiao-li Zhang
[1] H. Schelbert,et al. Noninvasive Assessment of Coronary Microcirculatory Function in Postmenopausal Women and Effects of Short-Term and Long-Term Estrogen Administration , 2002, Circulation.
[2] John O. Prior,et al. Coronary Circulatory Dysfunction in Insulin Resistance, Impaired Glucose Tolerance, and Type 2 Diabetes Mellitus , 2005, Circulation.
[3] W. Burchert,et al. Beneficial effects of atorvastatin on myocardial regions with initially low vasodilatory capacity at various stages of coronary artery disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[4] Cyrill Burger,et al. Bicycle exercise stress in PET for assessment of coronary flow reserve: repeatability and comparison with adenosine stress. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] T. Lüscher,et al. Coronary Heart Disease in Smokers: Vitamin C Restores Coronary Microcirculatory Function , 2000, Circulation.
[6] M. Phelps,et al. Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve. , 1995, Circulation.
[7] A. Zeiher,et al. Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome , 2004, Coronary artery disease.
[8] M. Phelps,et al. Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] M. Phelps,et al. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] H. Schelbert,et al. Myocardial Blood Flow at Rest and During Pharmacological Vasodilation in Cardiac Transplants During and After Successful Treatment of Rejection , 1994, Circulation.
[11] John O. Prior,et al. Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. , 2006, Journal of the American College of Cardiology.
[12] M. Pfisterer,et al. Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: contrasting myocardial blood flow responses to short- and long-term vitamin C administration. , 2003, Journal of the American College of Cardiology.
[13] O. Rimoldi,et al. Assessment of the long-term reproducibility of baseline and dobutamine-induced myocardial blood flow in patients with stable coronary artery disease. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] A. Beckett,et al. AKUFO AND IBARAPA. , 1965, Lancet.
[15] John O. Prior,et al. PET-measured responses of MBF to cold pressor testing correlate with indices of coronary vasomotion on quantitative coronary angiography. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] C. Wyss,et al. Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[17] H. Drexler,et al. Endothelial Dysfunction of the Coronary Microvasculature Is Associated With Impaired Coronary Blood Flow Regulation in Patients With Early Atherosclerosis , 1991, Circulation.
[18] Robert Elashoff,et al. Coronary Vasomotor Abnormalities in Insulin-Resistant Individuals , 2004, Annals of Internal Medicine.
[19] N. Tamaki,et al. Myocardial flow reserve is influenced by both coronary artery stenosis severity and coronary risk factors in patients with suspected coronary artery disease , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[20] I. Olivotto,et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.
[21] M. Phelps,et al. Semiquantitative assessment of myocardial blood flow and viability using polar map displays of cardiac PET images. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] S. Nekolla,et al. Relation of coronary vasoreactivity and coronary calcification in asymptomatic subjects with a family history of premature coronary artery disease , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[23] S. Nekolla,et al. Dysregulation of coronary microvascular reactivity in asymptomatic patients with type 2 diabetes mellitus , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[24] S. Nekolla,et al. Effects of nateglinide on myocardial microvascular reactivity in Type 2 diabetes mellitus – a randomized study using positron emission tomography , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[25] P. Kaufmann,et al. Myocardial blood flow measurement by PET: technical aspects and clinical applications. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] Hatem Alkadhi,et al. Repeatability of cold pressor test-induced flow increase assessed with H(2)(15)O and PET. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] A. Zeiher,et al. Endothelial Function: Cardiac Events , 2005, Circulation.
[28] S S Gambhir,et al. Quantification of Regional Myocardial Blood Flow Using 13N‐Ammonia and Reoriented Dynamic Positron Emission Tomographic Imaging , 1992, Circulation.
[29] D. Kuhl,et al. N‐13 Ammonia as an Indicator of Myocardial Blood Flow , 1981, Circulation.
[30] K. Kugiyama,et al. Endothelial function fluctuates with diurnal variation in the frequency of ischemic episodes in patients with variant angina. , 2002, Journal of the American College of Cardiology.
[31] A. Drzezga,et al. Deferoxamine improves coronary vascular responses to sympathetic stimulation in patients with type 1 diabetes mellitus , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[32] J. Yap,et al. Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[33] John O. Prior,et al. PET-measured heterogeneity in longitudinal myocardial blood flow in response to sympathetic and pharmacologic stress as a non-invasive probe of epicardial vasomotor dysfunction , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[34] J M Bland,et al. Statistical methods for assessing agreement between two methods of clinical measurement , 1986 .
[35] John O. Prior,et al. Determinants of myocardial blood flow response to cold pressor testing and pharmacologic vasodilation in healthy humans , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[36] Michael Kreissl,et al. Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events. , 2005, Journal of the American College of Cardiology.
[37] John O. Prior,et al. Chronic Inflammation and Impaired Coronary Vasoreactivity in Patients With Coronary Risk Factors , 2004, Circulation.
[38] E. Hoffman,et al. Validation of PET-acquired input functions for cardiac studies. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[39] H. Drexler,et al. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. , 1989, Journal of the American College of Cardiology.
[40] G. Hutchins,et al. Interobserver and interstudy variability of myocardial blood flow and flow-reserve measurements with nitrogen 13 ammonia-labeled positron emission tomography , 1995, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[41] John O. Prior,et al. Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes , 2006, Heart.